Nextrials' Prism Achieves Compliance Certification
San Ramon, CA-April 6, 2009-Nextrials, Inc., a leader in clinical research software and services, today announced that its award-winning Prism® data capture and clinical trial management platform has achieved certification for compliance with federally recognized Healthcare Information Technology Standards Panel (HITSP) Interoperability Specifications. The company successfully completed compliance testing at the 10th Annual IHE North America Connectathon by demonstrating Prism’s integration of its electronic data capture (EDC) platform used in clinical trials with platforms used by healthcare organizations to maintain electronic health records (EHR) for patients.
Administered by the American National Standards Institute (ANSI), HITSP is a cooperative effort with strategic partners such as the Healthcare Information and Management Systems Society (HIMSS), Integrating the Healthcare Enterprise (IHE), Advanced Technology Institute (ATI) and Booz Allen Hamilton.
Nextrials is again demonstrating Prism’s interoperability at the HIMSS 2009 Interoperability Showcase, part of the 2009 Annual Healthcare Information and Management Systems Society’s Conference & Exhibition, being held April 4-8 in Chicago. Conference attendees can find the showcase in Booth 7750 in the North Hall of McCormick Place.
“Nextrials has dedicated a significant amount of time toward support for ANSI’s work to promote the development and adoption of HITSP standards,” explained James Rogers, CEO and co-founder of Nextrials. “As an early implementer of HITSP interoperability specifications, we recognize the value of integrating electronic health records within clinical trial management systems, which will advance the continuum of patient care and further future clinical research.”
Nextrials’ award-winning Prism melds sophisticated clinical trial management functionality with electronic data capture in a single, integrated package. It is currently used worldwide by biopharmaceutical and medical device R&D teams developing novel treatments and therapeutics.
About Nextrials
Founded by pharmaceutical researchers in 1999, Nextrials offers today’s most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. Prism®, its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,000 research sites to streamline the initiation and management of clinical trials. The company is headquartered in the San Francisco Bay area. For more information, visit www.nextrials.com or call 925-355-3000.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
